Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3356885 | Indian Journal of Rheumatology | 2013 | 5 Pages |
Abstract
5.9% and 21.9% of RA were in remission based on DAS28 (3) ESR and DAS28 (3) CRP respectively and 12% and 10% of RA patients were in LDA based on DAS28 (3) ESR and DAS28 (3) CRP respectively at the point of our study. DAS (3) CRP overestimate remission compared to DAS28 (3) ESR.
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
S. Chandrashekara, B.U. Priyanka,